544 related articles for article (PubMed ID: 33329549)
1. Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes.
Qi Y; Liu B; Sun Q; Xiong X; Chen Q
Front Immunol; 2020; 11():578877. PubMed ID: 33329549
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors in Human Glioma Microenvironment.
Ghouzlani A; Kandoussi S; Tall M; Reddy KP; Rafii S; Badou A
Front Immunol; 2021; 12():679425. PubMed ID: 34305910
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment.
Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q
Front Immunol; 2021; 12():730289. PubMed ID: 34659216
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for glioma: from illusion to realistic prospects?
Dietrich PY; Dutoit V; Walker PR
Am Soc Clin Oncol Educ Book; 2014; ():51-9. PubMed ID: 24857060
[TBL] [Abstract][Full Text] [Related]
5. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma.
Zhang N; Wei L; Ye M; Kang C; You H
Front Immunol; 2020; 11():592612. PubMed ID: 33329578
[TBL] [Abstract][Full Text] [Related]
6. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
7. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.
Ott M; Tomaszowski KH; Marisetty A; Kong LY; Wei J; Duna M; Blumberg K; Ji X; Jacobs C; Fuller GN; Langford LA; Huse JT; Long JP; Hu J; Li S; Weinberg JS; Prabhu SS; Sawaya R; Ferguson S; Rao G; Lang FF; Curran MA; Heimberger AB
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32721947
[TBL] [Abstract][Full Text] [Related]
8. Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance.
Li Y; Liu J; Gao L; Liu Y; Meng F; Li X; Qin FX
Immunol Lett; 2020 Apr; 220():88-96. PubMed ID: 30885690
[TBL] [Abstract][Full Text] [Related]
9. Emerging principles of brain immunology and immune checkpoint blockade in brain metastases.
Fares J; Ulasov I; Timashev P; Lesniak MS
Brain; 2021 May; 144(4):1046-1066. PubMed ID: 33893488
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte-targeted immune checkpoint modulation in glioma.
Kelly WJ; Giles AJ; Gilbert M
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051289
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
[TBL] [Abstract][Full Text] [Related]
12. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
Zhu X; Fang Y; Chen Y; Chen Y; Hong W; Wei W; Tu J
Life Sci; 2023 May; 320():121558. PubMed ID: 36889666
[TBL] [Abstract][Full Text] [Related]
13. Bacteria Synergized with PD-1 Blockade Enhance Positive Feedback Loop of Cancer Cells-M1 Macrophages-T Cells in Glioma.
Chen Q; Zheng Y; Chen X; Xing Y; Zhang J; Yan X; Zhang Q; Wu D; Chen Z
Adv Sci (Weinh); 2024 May; 11(20):e2308124. PubMed ID: 38520726
[TBL] [Abstract][Full Text] [Related]
14. Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice.
Stessin AM; Clausi MG; Zhao Z; Lin H; Hou W; Jiang Z; Duong TQ; Tsirka SE; Ryu S
J Neurooncol; 2020 May; 147(3):547-555. PubMed ID: 32215786
[TBL] [Abstract][Full Text] [Related]
15. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.
Maxwell R; Jackson CM; Lim M
Curr Treat Options Oncol; 2017 Aug; 18(8):51. PubMed ID: 28785997
[TBL] [Abstract][Full Text] [Related]
16. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.
Ghidini M; Fusco N; Salati M; Khakoo S; Tomasello G; Petrelli F; Trapani D; Petrillo A
Curr Drug Targets; 2021; 22(9):1021-1033. PubMed ID: 33563194
[TBL] [Abstract][Full Text] [Related]
17. An immune signature to predict the prognosis of
Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment.
Arrieta VA; Dmello C; McGrail DJ; Brat DJ; Lee-Chang C; Heimberger AB; Chand D; Stupp R; Sonabend AM
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647828
[TBL] [Abstract][Full Text] [Related]
19. CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma.
Tanaka S; Ohgidani M; Hata N; Inamine S; Sagata N; Shirouzu N; Mukae N; Suzuki SO; Hamasaki H; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Funakoshi Y; Iwaki T; Hosoi M; Iihara K; Mizoguchi M; Kato TA
Front Immunol; 2021; 12():670131. PubMed ID: 34267749
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Aslan K; Turco V; Blobner J; Sonner JK; Liuzzi AR; Núñez NG; De Feo D; Kickingereder P; Fischer M; Green E; Sadik A; Friedrich M; Sanghvi K; Kilian M; Cichon F; Wolf L; Jähne K; von Landenberg A; Bunse L; Sahm F; Schrimpf D; Meyer J; Alexander A; Brugnara G; Röth R; Pfleiderer K; Niesler B; von Deimling A; Opitz C; Breckwoldt MO; Heiland S; Bendszus M; Wick W; Becher B; Platten M
Nat Commun; 2020 Feb; 11(1):931. PubMed ID: 32071302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
